AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹21,330 Cr | ₹19,653 Cr | ₹17,667 Cr | ₹15,510 Cr | ₹13,578 Cr |
What is the latest Total Non-Current Assets ratio of AUROBINDO PHARMA ?
Year | Total Non-Current Assets |
---|---|
Mar2025 | ₹21,330 Cr |
Mar2024 | ₹19,653 Cr |
Mar2023 | ₹17,667 Cr |
Mar2022 | ₹15,510 Cr |
Mar2021 | ₹13,578 Cr |
How is Total Non-Current Assets of AUROBINDO PHARMA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹21,330 Cr | 8.53 | |
Mar2024 | ₹19,653 Cr | 11.24 | |
Mar2023 | ₹17,667 Cr | 13.90 | |
Mar2022 | ₹15,510 Cr | 14.23 | |
Mar2021 | ₹13,578 Cr | - |
Compare Total Non-Current Assets of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹64,448.5 Cr | 6.3% | 5.4% | -30.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,197.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,634.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹126,082.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,167.0 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,783.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 6.3% |
5.4% |
-30.8% |
SENSEX | 1% |
2.1% |
0.5% |
You may also like the below Video Courses